No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease

被引：29

作者：

Sodeyama, N

Yamada, M

Itoh, Y

Suematsu, N

Matsushita, M

Otomo, E

Mizusawa, H

机构：

[1] Tokyo Med & Dent Univ, Dept Neurol, Bunkyo Ku, Tokyo 1138519, Japan

[2] Yokufukai Geriatr Hosp, Dept Internal Med, Tokyo, Japan

[3] Yokufukai Geriatr Hosp, Dept Pathol, Tokyo, Japan

[4] Tokyo Inst Psychiat, Dept Neuropathol, Tokyo, Japan

来源：

NEUROLOGY | 1999年 / 53卷 / 05期

关键词：

AD; paraoxonase; polymorphism; neuropathologic change;

D O I：

10.1212/WNL.53.5.1146

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Both AD and paraoxonase (PON) have been reported to be related to lipids and atherosclerosis, suggesting that the PON gene (PON) is a possible genetic risk factor for AD. We found no association of PON polymorphism with severity of atherosclerosis, densities of AD-type, neuropathologic change, or development of AD in 47 AD and 90 nondemented patients. Our study suggests that PON polymorphism does not play a. causal role in the development of atherosclerosis or AD.

引用

收藏

页码：1146 / 1148

页数：3

相关论文

共 10 条

[1] IDENTIFICATION OF A DISTINCT HUMAN HIGH-DENSITY-LIPOPROTEIN SUBSPECIES DEFINED BY A LIPOPROTEIN-ASSOCIATED PROTEIN, K-45 - IDENTITY OF K-45 WITH PARAOXONASE [J].

BLATTER, MC ;

JAMES, RW ;

MESSMER, S ;

BARJA, F ;

POMETTA, D .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 211 (03) :871-879

[2] Microvessels from Alzheimer's disease brains kill neurons in vitro [J].

Grammas, P ;

Moore, P ;

Weigel, PH .

AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) :337-342

[3] Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [J].

Hofman, A ;

Ott, A ;

Breteler, MMB ;

Bots, ML ;

Slooter, AJC ;

vanHarskamp, F ;

vanDuijn, CN ;

Van Broeckhoven, C ;

Grobbee, DE .

LANCET, 1997, 349 (9046) :151-154

[4] THE MOLECULAR-BASIS OF THE HUMAN SERUM PARAOXONASE ACTIVITY POLYMORPHISM [J].

HUMBERT, R ;

ADLER, DA ;

DISTECHE, CM ;

HASSETT, C ;

OMIECINSKI, CJ ;

FURLONG, CE .

NATURE GENETICS, 1993, 3 (01) :73-76

[5] Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification [J].

Mackness, B ;

Mackness, MI ;

Arrol, S ;

Turkie, W ;

Durrington, PN .

FEBS LETTERS, 1998, 423 (01) :57-60

[6] GLN-ARG192 POLYMORPHISM OF PARAOXONASE AND CORONARY HEART-DISEASE IN TYPE-2 DIABETES [J].

RUIZ, J ;

BLANCHE, H ;

JAMES, RW ;

GARIN, MCB ;

VAISSE, C ;

CHARPENTIER, G ;

COHEN, N ;

MORABIA, A ;

PASSA, P ;

FROGUEL, P .

LANCET, 1995, 346 (8979) :869-872

[7]

SAHA N, 1991, CLIN GENET, V40, P277

[8] DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease [J].

Sanghera, DK ;

Aston, CE ;

Saha, N ;

Kamboh, MI .

AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (01) :36-44

[9] Presenilin 1 intronic polymorphism, is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease [J].

Sodeyama, N ;

Itoh, Y ;

Suematsu, N ;

Matsushita, M ;

Otomo, E ;

Mizusawa, H ;

Yamada, M .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (04) :548-551

[10] Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease [J].

WavrantDeVrieze, F ;

PerezTur, J ;

Lambert, JC ;

Frigard, B ;

Pasquier, F ;

Delacourte, A ;

Amouyel, P ;

Hardy, J ;

ChartierHarlin, MC .

NEUROSCIENCE LETTERS, 1997, 227 (01) :68-70